Accelerate's PhenoTest BC kit gets CE Mark

By LabPulse.com staff writers

August 2, 2019 -- A version of Accelerate Diagnostics' PhenoTest blood culture (BC) kit that includes new antimicrobial susceptibility tests and satisfies European regulatory requirements now has the CE Mark, the company reported.

The new kit allows antimicrobial testing for the combination treatments ceftazidime-avibactam and ceftolozane-tazobactam for Enterobacteriaceae and Pseudomonas aeruginosa bacteria and trimethoprim-sulfamethoxazole for Acinetobacter baumannii.

In compliance with guidance from the European Committee on Antimicrobial Susceptibility Testing, the kit also incorporates updates to clinical interpretive breakpoints, the company said in a statement. The kit identifies organisms within two hours and provides antimicrobial susceptibility results in seven hours, according to Accelerate.

T2 stretches out globally with sepsis assays
T2 Biosystems is introducing its T2Bacteria and T2Candida whole-blood panel diagnostics in five new countries -- Estonia, Greece, Ireland, Saudi Arabia,...
T2Bacteria panel proves itself, but will hospitals buy in?
The T2Bacteria panel was accurate and fast for detecting five common kinds of bacteria in the blood in a multicenter study published May 13 in the Annals...

Copyright © 2019 LabPulse.com

Last Updated np 8/2/2019 5:40:27 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current